Zobrazeno 1 - 10
of 100
pro vyhledávání: '"Eva L. Feldman"'
Autor:
Stephanie A. Eid, Phillipe D. O’Brien, Lucy M. Hinder, John M. Hayes, Faye E. Mendelson, Hongyu Zhang, Lixia Zeng, Katharina Kretzler, Samanthi Narayanan, Steven F. Abcouwer, Frank C. Brosius, Subramaniam Pennathur, Masha G. Savelieff, Eva L. Feldman
Publikováno v:
Biology, Vol 9, Iss 11, p 347 (2020)
Microvascular complications account for the significant morbidity associated with diabetes. Despite tight glycemic control, disease risk remains especially in type 2 diabetes (T2D) patients and no therapy fully prevents nerve, retinal, or renal damag
Externí odkaz:
https://doaj.org/article/ae980c3ab17d496ca000323a2cc2eade
Autor:
Phillipe D. O'Brien, Junguk Hur, John M. Hayes, Carey Backus, Stacey A. Sakowski, Eva L. Feldman
Publikováno v:
Neurobiology of Disease, Vol 73, Iss , Pp 348-355 (2015)
Given the lack of treatments for diabetic neuropathy (DN), a common diabetic complication, accurate disease models are necessary. Characterization of the leptin-deficient BTBR ob/ob mouse, a type 2 diabetes model, demonstrated that the mice develop r
Externí odkaz:
https://doaj.org/article/cb593583f08240df9678cd7eaaa1e35c
Autor:
Eva L. Feldman, Patrice Fort, Steven F. Abcouwer, Kelli M. Sas, Thomas W. Gardner, Stephanie Eid, Subramaniam Pennathur
Publikováno v:
Diabetologia
Diabetes adversely affects multiple organs, including the kidney, eye and nerve, leading to diabetic kidney disease, diabetic retinopathy and diabetic neuropathy, respectively. In both type 1 and type 2 diabetes, tissue damage is organ specific and i
Autor:
Jane E.B. Reusch, Vera Fridman, Bryan C. Bergman, Eva L. Feldman, Stefan Sillau, Simona Zarini, Brian C. Callaghan, Kathleen A. Harrison
Publikováno v:
J Diabetes Complications
Recent studies suggest that the accumulation of atypical, 1-deoxysphingolipids that lack the C1 hydroxyl group may be associated with diabetic neuropathy (DN). We hypothesized that specific plasma 1-deoxysphingolipids associate with DN severity, and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::105c83c3e055a2ca831e3dcdce19d2bc
https://europepmc.org/articles/PMC8114795/
https://europepmc.org/articles/PMC8114795/
Autor:
Páll Karlsson, Hatice Tankisi, Sandra Sif Gylfadottir, Brian C. Callaghan, Astrid Juhl Terkelsen, David L.H. Bennett, Karolina Snopek Khan, Morten Charles, Nanna B. Finnerup, Andreas C. Themistocleous, Henning Andersen, Mustapha Itani, Søren H. Sindrup, Troels S. Jensen, Alexander Gramm Kristensen, Signe T Andersen, Eva L. Feldman
Publikováno v:
Brain
Jensen, T S, Karlsson, P, Gylfadottir, S S, Andersen, S T, Bennett, D L, Tankisi, H, Finnerup, N B, Terkelsen, A J, Khan, K, Themistocleous, A C, Kristensen, A G, Itani, M, Sindrup, S H, Andersen, H, Charles, M, Feldman, E L & Callaghan, B C 2021, ' Painful and non-painful diabetic neuropathy, diagnostic challenges and implications for future management ', Brain, vol. 144, no. 6, pp. 1632–1645 . https://doi.org/10.1093/brain/awab079
Jensen, T S, Karlsson, P, Gylfadottir, S S, Andersen, S T, Bennett, D L, Tankisi, H, Finnerup, N B, Terkelsen, A J, Khan, K, Themistocleous, A C, Kristensen, A G, Itani, M, Sindrup, S H, Andersen, H, Charles, M, Feldman, E L & Callaghan, B C 2021, ' Painful and non-painful diabetic neuropathy, diagnostic challenges and implications for future management ', Brain : a journal of neurology, vol. 144, no. 6, pp. 1632-1645 . https://doi.org/10.1093/brain/awab079
Jensen, T S, Karlsson, P, Gylfadottir, S S, Andersen, S T, Bennett, D L, Tankisi, H, Finnerup, N B, Terkelsen, A J, Khan, K, Themistocleous, A C, Kristensen, A G, Itani, M, Sindrup, S H, Andersen, H, Charles, M, Feldman, E L & Callaghan, B C 2021, ' Painful and non-painful diabetic neuropathy, diagnostic challenges and implications for future management ', Brain, vol. 144, no. 6, pp. 1632–1645 . https://doi.org/10.1093/brain/awab079
Jensen, T S, Karlsson, P, Gylfadottir, S S, Andersen, S T, Bennett, D L, Tankisi, H, Finnerup, N B, Terkelsen, A J, Khan, K, Themistocleous, A C, Kristensen, A G, Itani, M, Sindrup, S H, Andersen, H, Charles, M, Feldman, E L & Callaghan, B C 2021, ' Painful and non-painful diabetic neuropathy, diagnostic challenges and implications for future management ', Brain : a journal of neurology, vol. 144, no. 6, pp. 1632-1645 . https://doi.org/10.1093/brain/awab079
Peripheral neuropathy is one of the most common complications of both type 1 and type 2 diabetes. Up to half of patients with diabetes develop neuropathy during the course of their disease, which is accompanied by neuropathic pain in 30–40% of case
Publikováno v:
Clinical Epigenetics
Diabetic peripheral neuropathy (DPN) is the most common complication of type 2 diabetes (T2D). Although the cellular and molecular mechanisms of DPN are poorly understood, we and others have shown that altered gene expression and DNA methylation are
Publikováno v:
Pediatric diabetesREFERENCES. 22(2)
Pediatric neuropathy attributed to metabolic dysfunction is a well-known complication in children and youth with type 1 diabetes. Moreover, the rise of obesity and in particular of type 2 diabetes may cause an uptick in pediatric neuropathy incidence
Publikováno v:
Diabetologia
Autor:
Morten Charles, Amy E. Rumora, Signe T Andersen, Troels S. Jensen, Eva L. Feldman, Fadhl M. Al-Akwaa, Brian C. Callaghan, Marit E. Jørgensen
Publikováno v:
Diabetes. 69
Peripheral neuropathy (PN) is a common complication of diabetes that develops in up to 50% of people with diabetes. Obesity and the metabolic syndrome are risk factors for PN in patients with type 2 diabetes (T2D). However, the lipid metabolites asso